These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1436301)

  • 21. Nafamostat mesilate, as a treatment for heparin resistance, is not associated with perioperative ischemic stroke in patients undergoing cardiac surgery with cardiopulmonary bypass.
    Kikura M; Tanaka K; Hiraiwa T; Tanaka K
    J Cardiothorac Vasc Anesth; 2012 Apr; 26(2):239-44. PubMed ID: 22019206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nafamostat Mesilate as an Anticoagulant During Continuous Renal Replacement Therapy in Patients With High Bleeding Risk: A Randomized Clinical Trial.
    Choi JY; Kang YJ; Jang HM; Jung HY; Cho JH; Park SH; Kim YL; Kim CD
    Medicine (Baltimore); 2015 Dec; 94(52):e2392. PubMed ID: 26717390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible Role of Electrolytes on the Formation of Precipitates during the Infusion of Nafamostat Mesilate in Hemodialysis.
    Yamasaki K; Nishi K; Tsukigawa K; Taguchi K; Otagiri M; Seo H
    Biol Pharm Bull; 2021; 44(2):259-265. PubMed ID: 33518678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adsorption of nafamostat mesilate by hemodialysis membranes.
    Inagaki O; Nishian Y; Iwaki R; Nakagawa K; Takamitsu Y; Fujita Y
    Artif Organs; 1992 Dec; 16(6):553-8. PubMed ID: 1482323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained Deterioration of Hepatic Oxygenation After Nafamostat Mesilate-Induced Anaphylactic Shock During Hemodiafiltration.
    Ookawara S; Ito K; Morishita Y
    Artif Organs; 2018 Jun; 42(6):674-675. PubMed ID: 29956358
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of uremic patients with heparin-induced thrombocytopenia requiring hemodialysis.
    Matsuo T; Wanaka K
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):459-64. PubMed ID: 18160571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between Intra-Circuit Activated Clotting Time and Incidence of Bleeding Complications during Continuous Renal Replacement Therapy using Nafamostat Mesilate: a Retrospective Pilot Observational Study.
    Miyatake Y; Makino S; Kubota K; Egi M; Mizobuchi S
    Kobe J Med Sci; 2017 Aug; 63(1):E30-E36. PubMed ID: 29434171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of nafamostat mesilate and unfractionated heparin as anticoagulants during continuous renal replacement therapy.
    Makino S; Egi M; Kita H; Miyatake Y; Kubota K; Mizobuchi S
    Int J Artif Organs; 2016 Jan; 39(1):16-21. PubMed ID: 26868216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous retroperitoneal bleeding: a case series.
    Yamamura H; Morioka T; Yamamoto T; Kaneda K; Mizobata Y
    BMC Res Notes; 2014 Sep; 7():659. PubMed ID: 25236774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma.
    Chen CL; Wang SD; Zeng ZY; Lin KJ; Kao ST; Tani T; Yu CK; Wang JY
    J Allergy Clin Immunol; 2006 Jul; 118(1):105-12. PubMed ID: 16815145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized controlled trial for efficacy of nafamostat mesilate in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Ohuchida J; Chijiiwa K; Imamura N; Nagano M; Hiyoshi M
    Pancreas; 2015 Apr; 44(3):415-21. PubMed ID: 25479585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nafamostat mesilate inhibits linezolid metabolism via its antioxidant effects.
    Kuriyama N; Matsumoto K; Morita K; Shimomura Y; Hara Y; Hasegawa D; Nakamura T; Yamashita C; Kato Y; Komura H; Nishida O
    Ther Apher Dial; 2020 Oct; 24(5):499-502. PubMed ID: 32524735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
    Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y
    Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients?
    Park KT; Kang DH; Choi CW; Cho M; Park SB; Kim HW; Kim DU; Chung CW; Yoon KT
    Pancreas; 2011 Nov; 40(8):1215-9. PubMed ID: 21775918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of nafamostat mesilate on the prevention of cerulein-induced acute pancreatitis.
    Lee JK; Ryu JK; Park JK; Lee SH; Yoon WJ; Kim YT; Jung HC; Yoon YB
    Pancreas; 2008 Apr; 36(3):255-60. PubMed ID: 18362838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticoagulation During Extracorporeal Membrane Oxygenation; Nafamostat Mesilate Versus Heparin.
    Lim JY; Kim JB; Choo SJ; Chung CH; Lee JW; Jung SH
    Ann Thorac Surg; 2016 Aug; 102(2):534-9. PubMed ID: 27083248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nafamostat mesilate as a regional anticoagulant in patients with bleeding complications during extracorporeal membrane oxygenation.
    Park JH; Her C; Min HK; Kim DK; Park SH; Jang HJ
    Int J Artif Organs; 2015 Nov; 38(11):595-9. PubMed ID: 26728787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in the adsorption of nafamostat mesilate between polyester-polymer alloy and polysulfone membranes.
    Goto S; Ookawara S; Saito A
    J Artif Organs; 2017 Jun; 20(2):138-144. PubMed ID: 27896500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aprotinin and nafamostat mesilate in liver surgery: effect on blood loss.
    Pereboom IT; de Boer MT; Porte RJ; Molenaar IQ
    Dig Surg; 2007; 24(4):282-7. PubMed ID: 17657153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypersensitivity to heparin; a case report.
    Katoh S; Terashima S; Nakahara Y; Yamada H; Tatsukawa H; Ida K; Nakagawa M
    Nihon Jinzo Gakkai Shi; 1993 Apr; 35(4):411-4. PubMed ID: 8341021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.